Ani Pharmaceuticals, Inc
$1.63B- Market cap
- $1.60B
- Debt
- +$309.11M
- Cash
- −$285.59M
Capital structure 84% equity / 16% debt · EV / Revenue 1.84x · EV / EBITDA 7.53x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
ANIP · current priceP/E 21.46x
$71.25Latest market snapshot
Implied fair value · at OKE's multiple
$58.4717.9% below market
3.32 ANIP EPS (TTM)×17.61x OKE P/E=$58.47
Market $71.25Implied $58.47
OKE · current priceP/E 17.61x
$95.45Latest market snapshot
Implied fair value · at ANIP's multiple
$116.3221.9% above market
5.42 OKE EPS (TTM)×21.46x ANIP P/E=$116.32
Market $95.45Implied $116.32